James Bauersmith

James Bauersmith

Director/Board Member chez LANNETT COMPANY, INC.

Health Technology
Consumer Services
Finance

Profil

James is an experienced healthcare executive with over 20 years of experience across a variety of healthcare segments.
He joined UPMC Enterprises in August of 2021 as Vice President of Translational Sciences.
Before joining Enterprises, James was the Chief Strategic Officer and General Counsel of ByHeart, Inc., an infant formula company, where he led the company’s FDA strategy, managed all of their legal affairs and led the acquisition and set-up of the company’s manufacturing facility.
Prior to his role at ByHeart, James worked in the pharmaceutical sector for over 15 years where he held a variety of leadership positions at Fresenius Kabi, where he was the SVP overseeing the company’s portfolio and marketing strategy unit, and Amneal Pharmaceuticals where he oversaw the corporate development and procurement groups and was part of the executive management team.
Before his tenure at Fresenius and Amneal, James spent 10 years practicing law, first as an attorney in New York with Haug Partners and then as in-house counsel at Teva Pharmaceuticals where he managed the company’s Hatch Waxman Patent litigations.
He earned a B.S.
from the University of Notre Dame, a J.D.
from the Pennsylvania State University School of Law, and an M.S.
of Bioscience and Biotechnology from Drexel University.
He is a registered U.S.
Patent Attorney and maintains an active Pennsylvania law license.
At Enterprises, James focuses his time on identifying, analyzing and structuring investment opportunities that address unmet therapeutic need and align with UPMC’s vision of bringing life changing medicine to patients.

Postes actifs de James Bauersmith

SociétésPosteDébut
LANNETT COMPANY, INC. Director/Board Member -
Corporate Officer/Principal 01/08/2021
Tous les postes actifs de James Bauersmith

Anciens postes connus de James Bauersmith

SociétésPosteFin
General Counsel 01/10/2021
AMNEAL PHARMACEUTICALS, INC. Corporate Officer/Principal 30/06/2019
FRESENIUS SE & CO. KGAA Corporate Officer/Principal 31/05/2018
AKORN, INC. Director/Board Member -
Voir l'expérience en détail de James Bauersmith

Formation de James Bauersmith

University of Notre Dame Undergraduate Degree
Drexel University Graduate Degree
The Pennsylvania State University Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Bauersmith

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
LANNETT COMPANY, INC.

Health Technology

FRESENIUS SE & CO. KGAA

Health Technology

AMNEAL PHARMACEUTICALS, INC.

Health Technology

Entreprise privées3

Health Technology

Finance

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Bauersmith